Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
OBA-PHARMA ApS
APS
Active
Advertising protection
CVR 19995607
Sølvgade 23, 1307
København K
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1997 · 29 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
OBA-PHARMA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
4M
3M
2M
1M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 3M (+200% vs 2022)
3M
+200%
2023
2024: 3M (0% vs 2023)
3M
0%
2024
2025: 2M (-33% vs 2024)
2M
-33%
2025
EBITDA
DKK millions
4M
3M
2M
1M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 3M (+200% vs 2022)
3M
+200%
2023
2024: 3M (0% vs 2023)
3M
0%
2024
2025: 2M (-33% vs 2024)
2M
-33%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
1.988
3.402
2.853
1.041
1.334
Staff expenses
-0
-0
-0
-0
-0
EBITDA
1.988
3.402
2.853
1.041
1.334
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
1.988
3.402
2.853
1.041
1.334
Net financials
-103
22
-193
-76
-49
Profit before tax
1.885
3.424
2.660
966
1.284
Tax
409
753
586
213
283
Net profit
1.476
2.671
2.073
752
1.002
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
7.550
5.880
11.594
6.613
4.889
Equity
1.602
674
2.245
1.921
2.169
Long-term debt
0
753
586
213
283
Short-term debt
5.948
4.452
8.762
4.479
2.437
Total debt
5.948
5.206
9.349
4.692
2.720
Financial ratios
5-year trend
EBITDA margin (of gross profit)
100,0 %
This company
2021
2025
Equity ratio
21,2 %
This company
38,2 %
Market median
This company
Market median
45% below market
2021
2025
Return on equity
92,1 %
This company
18,4 %
Market median
This company
Market median
401% above market
2021
2025
Net profit margin (of gross profit)
74,2 %
This company
2021
2025
Asset turnover (of gross profit)
0,26×
This company
2021
2025
Debt / equity
3,71×
This company
0,62×
Market median
This company
Market median
498% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-10-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
View
PDF
More on OBA-PHARMA ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
